Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The role of CIP2A in oral squamous cell carcinoma.

× No keyword cloud information.

14 in total

1. Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis.

Authors: Xinxin Liu; Yurong Chai; Jitian Li; Pengfei Ren; Mei Liu; Liping Dai; Wei Qian; Wenjie Li; Jian-Ying Zhang
Journal: Tumour Biol Date: 2014-01-08

2. CIP2A is overexpressed and involved in the pathogenesis of chronic myelocytic leukemia by interacting with breakpoint cluster region-Abelson leukemia virus.

Authors: Juandong Wang; Tao Huang; Jianzhi Sun; Yuan Yu; Zhifang Liu; Wenjuan Li; Jihui Jia; Chunyan Chen
Journal: Med Oncol Date: 2014-07-15 Impact factor: 3.064

3. CIP2A is overexpressed in osteosarcoma and regulates cell proliferation and invasion.

Authors: Mo Zhai; Lin Cong; Yaxin Han; Guanjun Tu
Journal: Tumour Biol Date: 2013-09-08

4. CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis.

Authors: Peng Xu; Xiao-Lan Xu; Qiang Huang; Zhi-Hong Zhang; Yan-Bei Zhang
Journal: Med Oncol Date: 2011-08-28 Impact factor: 3.064

5. CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma.

Authors: Yijun Xue; Gengqing Wu; Xiaoning Wang; Xiaofeng Zou; Guoxi Zhang; Rihai Xiao; Yuanhu Yuan; Dazhi Long; Jun Yang; Yuting Wu; Hui Xu; Folin Liu; Min Liu
Journal: Med Oncol Date: 2012-12-30 Impact factor: 3.064

6. CIP2A expression is associated with altered expression of epithelial-mesenchymal transition markers and predictive of poor prognosis in pancreatic ductal adenocarcinoma.

Authors: Lei Wang; Feng Gu; Ning Ma; Lei Zhang; Jian-Min Bian; Hong-Yong Cao
Journal: Tumour Biol Date: 2013-04-09

The role of CIP2A in oral squamous cell carcinoma.

1. Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis.

2. CIP2A is overexpressed and involved in the pathogenesis of chronic myelocytic leukemia by interacting with breakpoint cluster region-Abelson leukemia virus.

3. CIP2A is overexpressed in osteosarcoma and regulates cell proliferation and invasion.

4. CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis.

5. CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma.

6. CIP2A expression is associated with altered expression of epithelial-mesenchymal transition markers and predictive of poor prognosis in pancreatic ductal adenocarcinoma.

7. Overexpression and small molecule-triggered downregulation of CIP2A in lung cancer.

8. Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival.

9. CIP2A protein expression in high-grade, high-stage bladder cancer.

10. Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC).